register

News & Trends - MedTech & Diagnostics

ASO warns against US-style managed care as ACCC considers authorising buying group

Health Industry Hub | June 21, 2021 |

MedTech News: The private health insurers lobby regularly with the Federal Government claiming a crisis of affordability in private health insurance and request for increased funding and regulatory changes designed to control the private healthcare sector.

In an interview with Health Industry Hub, Dr Peter Sumich, Vice President, Australian Society of Ophthalmologists (ASO), provided his views on health insurers seeking to enter the ownership of private medical and surgical facilities in Australia. He detailed the adverse impact of US-style managed care on clinicians, clinical practice and patient care, if this was to be adopted locally.

In light of the recent ACCC issued draft determination to authorise Honeysuckle Health (Cigna/nib health funds) to form a health services buying group, the ASO has launched an awareness campaign to alert Australians to the dangers of US-style managed healthcare and the potential adverse consequences for insured patients.

“This is another paradigm shifting moment where we have to see that this partnership between Cigna and nib is an inch too far,” stated Dr Sumich.

The ACCC draft recommendation allows for 40% of the Australian marketplace to be consumed by this joint venture, which will force other insurers to respond. Insurers can minimise payouts by organising discount health packages through bundling the doctor, hospital and treatment plan which they contract together based on minimal costs.

Managed care is very profitable for health insurers but can be disastrous for patients as experience in the US shows.

The ASO and other medical bodies including the AMA will attempt to persuade the Federal Government to protect privately insured patients by strengthening the Health Act and introducing anti-managed care legislation.

Contact your Local Federal Member. You may download the ASO template, change the text or add to it to personalise and send via email or post.


News & Trends - MedTech & Diagnostics

Roche Diagnostics MD bids farewell after two-decades, leading the organisation to new heights of success

Roche Diagnostics MD bids farewell after two-decades, leading the organisation to new heights of success

Health Industry Hub | April 19, 2024 |

Diagnostics & MedTech News: The Managing Director of Roche Diagnostics Australia, Allison Rossiter, has announced her resignation, effective September 2024. […]

More


News & Trends - Pharmaceuticals

Is Australia ready to play a leading role in precision nuclear medicines?

Is Australia ready to play a leading role in precision nuclear medicines?

Health Industry Hub | April 19, 2024 |

Pharma News: A newly released discussion paper unveils Australia’s preparedness to take the helm in the rise of the global […]

More


News & Trends - MedTech & Diagnostics

Minimally invasive procedure a first in epilepsy treatment

Minimally invasive procedure a first in epilepsy treatment

Health Industry Hub | April 19, 2024 |

MedTech & Diagnostics News: An Australian-first procedure utilising MRI-guided, minimally invasive surgery has been introduced for the treatment of epilepsy […]

More


News & Trends - Pharmaceuticals

BCNA joins international call to tackle breast cancer gaps and inequities

Stakeholders unite in international call to tackle breast cancer gaps and inequities

Health Industry Hub | April 19, 2024 |

Pharma News: Breast Cancer Network Australia (BCNA) has united in an international call to raise breast cancer care standards and […]

More


This content is copyright protected. Please subscribe to gain access.